K
Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
TSX:GUD
Price:
6.11 CAD
-0.49%
Market Closed
Updated:
May 19, 2024
Knight Therapeutics Inc
Income from Continuing Operations
|
Knight Therapeutics Inc
Income from Continuing Operations Peer Comparison
Comparables:
BHC
WEED
SNDL
CRON
C
CURA
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Income from Continuing Operations
-CA$17.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Income from Continuing Operations
-$479m
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
6%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Income from Continuing Operations
-CA$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Income from Continuing Operations
-CA$172m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Income from Continuing Operations
-$54.9m
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Income from Continuing Operations
-$563m
|
CAGR 3-Years
-119%
|
CAGR 5-Years
-343%
|
CAGR 10-Years
N/A
|
See Also
What is Knight Therapeutics Inc's Income from Continuing Operations?
Income from Continuing Operations
-17.4m
CAD
-17.4m
CAD
Based on the financial report for Mar 31, 2024, Knight Therapeutics Inc's Income from Continuing Operations amounts to -17.4m CAD.
What is Knight Therapeutics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-16%
-16%
Over the last year, the Income from Continuing Operations growth was -16%.
You don't have any saved screeners yet
